CPD
Beyond the jab: building vaccine confidence through post-vaccination care conversations
Are misconceptions driving more people away from vaccination than we realise? Community pharmacists are in a unique position to address questions, support decision-making, and strengthen vaccine confidence during engagement opportunities …
Navigating the Special Access Scheme and Section 19A: a practical guide for pharmacists
The Special Access Scheme (SAS) and Section 19A (S19A) provisions enable pharmacists to supply unapproved or temporarily approved medicines to help address unmet patient need. This article explains the associated …
The proton pump, the gastric mucosal barrier, and stomach and duodenal ulcers
Back to Basics with Peter Carroll The aim of this series of articles is to revisit and discuss some fundamental pharmacological, physiological and therapeutic concepts with the overall objective of …
Assessing systems and workflow
USING THE PDL RISK MANAGEMENT GUIDE FOR PHARMACISTS This series introduces pharmacists to the PDL Risk Management Guide for Pharmacists, and how it can be used in everyday pharmacy practice …
Improving asthma management in adults
The 2025 update to the National Asthma Council (NAC) Australia’s guideline for asthma in primary care, the Australian Asthma Handbook, emphasises significant changes in asthma management. By Debbie Rigby, advanced …
Food–medicine interactions: an update
Although many medicines can be taken safely with food, some have the potential for clinically significant food–medicine interactions that may reduce or increase the medicine’s effect, potentially causing harm to …
Foreseeing risk when introducing new services
USING THE PDL RISK MANAGEMENT GUIDE FOR PHARMACISTS This series introduces pharmacists to the PDL Risk Management Guide for Pharmacists, and how it can be used in everyday pharmacy …
Management of opioid overdose in a community setting
Evidence from Australian research highlights that pharmacist-led naloxone interventions significantly improve overdose response and survival rates, reinforcing the pharmacist’s role as a critical contributor to reducing opioid-related mortality. By Dr …
Vulvovaginal candidiasis: managing thrush in pharmacy
Also known as thrush, vulvovaginal candidiasis is a common infection caused by an overgrowth of yeasts that naturally occur in the vagina. This article aims to outline risk factors, symptoms, …
Calcitonin-gene related peptide antagonists use in pregnancy and lactation: a brief safety review
Calcitonin gene-related peptide (CGRP) therapies are the first medications developed specifically for migraine prevention. What is the latest evidence for their use and safety in pregnancy and lactation? By John …
Acute coronary syndromes: new guideline for diagnosis and management
A new guideline represents a significant advance in the diagnosis and management of people with suspected or confirmed acute coronary syndromes. By Karalyn Huxhagen BPharm, FPS, CredPharm (MMR), consultant pharmacist Learning …
UTI management—more than antibiotics
The growing problem of antimicrobial resistance means the non-antibiotic strategies should be considered for the prevention of recurrent urinary tract infections (UTIs). What are these non-antibiotic management options and how …